Annual FCF
$9.14 B
-$5.56 B-37.83%
31 December 2023
Summary:
Merck & Co annual free cash flow is currently $9.14 billion, with the most recent change of -$5.56 billion (-37.83%) on 31 December 2023. During the last 3 years, it has risen by +$3.32 billion (+56.99%). MRK annual FCF is now -37.83% below its all-time high of $14.71 billion, reached on 31 December 2022.MRK Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly FCF
$8.51 B
+$3.66 B+75.57%
30 September 2024
Summary:
Merck & Co quarterly free cash flow is currently $8.51 billion, with the most recent change of +$3.66 billion (+75.57%) on 30 September 2024. Over the past year, it has increased by +$1.69 billion (+24.84%). MRK quarterly FCF is now at all-time high.MRK Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM FCF
$14.84 B
+$1.69 B+12.88%
30 September 2024
Summary:
Merck & Co TTM free cash flow is currently $14.84 billion, with the most recent change of +$1.69 billion (+12.88%) on 30 September 2024. Over the past year, it has increased by +$1.67 billion (+12.71%). MRK TTM FCF is now -2.68% below its all-time high of $15.25 billion, reached on 30 September 2022.MRK TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
MRK Free Cash Flow Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | -37.8% | +24.8% | +12.7% |
3 y3 years | +57.0% | +134.7% | +76.4% |
5 y5 years | +10.1% | +160.4% | +65.4% |
MRK Free Cash Flow High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3 years | -37.8% | +57.0% | at high | +1245.1% | -2.7% | +76.4% |
5 y | 5 years | -37.8% | +57.0% | at high | +1245.1% | -2.7% | +169.0% |
alltime | all time | -37.8% | +864.8% | at high | +436.9% | -2.7% | +3563.3% |
Merck & Co Free Cash Flow History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sept 2024 | - | $8.51 B(+75.6%) | $14.84 B(+12.9%) |
June 2024 | - | $4.85 B(+117.4%) | $13.15 B(+19.1%) |
Mar 2024 | - | $2.23 B(-400.0%) | $11.04 B(+20.7%) |
Dec 2023 | $9.14 B(-37.8%) | -$743.00 M(-110.9%) | $9.14 B(-30.6%) |
Sept 2023 | - | $6.82 B(+148.8%) | $13.17 B(+21.6%) |
June 2023 | - | $2.74 B(+725.0%) | $10.83 B(-3.9%) |
Mar 2023 | - | $332.00 M(-89.9%) | $11.26 B(-23.4%) |
Dec 2022 | $14.71 B(+52.2%) | $3.28 B(-26.7%) | $14.71 B(-3.6%) |
Sept 2022 | - | $4.48 B(+41.1%) | $15.25 B(+5.9%) |
June 2022 | - | $3.17 B(-16.0%) | $14.40 B(+13.1%) |
Mar 2022 | - | $3.78 B(-1.2%) | $12.73 B(+31.8%) |
Dec 2021 | $9.66 B(+65.9%) | $3.82 B(+5.5%) | $9.66 B(+14.8%) |
Sept 2021 | - | $3.63 B(+141.0%) | $8.41 B(+52.5%) |
June 2021 | - | $1.50 B(+112.1%) | $5.52 B(-19.0%) |
Mar 2021 | - | $709.00 M(-72.5%) | $6.81 B(+17.0%) |
Dec 2020 | $5.82 B(-42.2%) | $2.58 B(+253.7%) | $5.82 B(-16.9%) |
Sept 2020 | - | $728.00 M(-74.0%) | $7.01 B(-26.6%) |
June 2020 | - | $2.80 B(-1103.6%) | $9.55 B(+5.5%) |
Mar 2020 | - | -$279.00 M(-107.4%) | $9.05 B(-10.1%) |
Dec 2019 | $10.07 B(+21.2%) | $3.76 B(+15.1%) | $10.07 B(+12.2%) |
Sept 2019 | - | $3.27 B(+41.9%) | $8.97 B(+14.4%) |
June 2019 | - | $2.30 B(+210.7%) | $7.85 B(-6.0%) |
Mar 2019 | - | $741.00 M(-72.2%) | $8.34 B(+0.4%) |
Dec 2018 | $8.31 B(+82.1%) | $2.66 B(+24.4%) | $8.31 B(-7.2%) |
Sept 2018 | - | $2.14 B(-23.5%) | $8.95 B(+72.2%) |
June 2018 | - | $2.80 B(+297.0%) | $5.20 B(-2.3%) |
Mar 2018 | - | $705.00 M(-78.7%) | $5.32 B(+16.6%) |
Dec 2017 | $4.56 B(-47.9%) | $3.30 B(-305.0%) | $4.56 B(+5.1%) |
Sept 2017 | - | -$1.61 B(-155.1%) | $4.34 B(-49.0%) |
June 2017 | - | $2.92 B(-5617.0%) | $8.51 B(+24.9%) |
Mar 2017 | - | -$53.00 M(-101.7%) | $6.82 B(-22.2%) |
Dec 2016 | $8.76 B(-22.2%) | $3.08 B(+20.3%) | $8.76 B(-7.1%) |
Sept 2016 | - | $2.56 B(+109.1%) | $9.43 B(-4.4%) |
June 2016 | - | $1.23 B(-35.3%) | $9.87 B(-10.9%) |
Mar 2016 | - | $1.89 B(-49.5%) | $11.07 B(-1.7%) |
Dec 2015 | $11.26 B(+98.4%) | $3.75 B(+25.3%) | $11.26 B(+126.1%) |
Sept 2015 | - | $3.00 B(+23.5%) | $4.98 B(-17.2%) |
June 2015 | - | $2.43 B(+16.6%) | $6.01 B(+7.4%) |
Mar 2015 | - | $2.08 B(-182.4%) | $5.60 B(-1.3%) |
Dec 2014 | $5.67 B(-43.9%) | -$2.52 B(-162.7%) | $5.67 B(-47.5%) |
Sept 2014 | - | $4.03 B(+100.1%) | $10.79 B(+4.2%) |
June 2014 | - | $2.01 B(-6.6%) | $10.36 B(+0.9%) |
Mar 2014 | - | $2.16 B(-17.0%) | $10.27 B(+1.6%) |
Dec 2013 | $10.11 B(+25.3%) | $2.60 B(-27.7%) | $10.11 B(+18.3%) |
Sept 2013 | - | $3.59 B(+86.7%) | $8.54 B(+11.3%) |
June 2013 | - | $1.93 B(-3.3%) | $7.67 B(-6.8%) |
Mar 2013 | - | $1.99 B(+93.0%) | $8.23 B(+2.1%) |
Dec 2012 | $8.07 B(-24.3%) | $1.03 B(-62.2%) | $8.07 B(-16.5%) |
Sept 2012 | - | $2.73 B(+9.5%) | $9.67 B(-12.8%) |
June 2012 | - | $2.49 B(+36.5%) | $11.09 B(+0.0%) |
Mar 2012 | - | $1.82 B(-30.7%) | $11.09 B(+4.0%) |
Dec 2011 | $10.66 B(+16.6%) | $2.63 B(-36.6%) | $10.66 B(-2.3%) |
Sept 2011 | - | $4.15 B(+66.7%) | $10.91 B(+21.0%) |
June 2011 | - | $2.49 B(+78.0%) | $9.02 B(-5.3%) |
Mar 2011 | - | $1.40 B(-51.5%) | $9.52 B(+4.1%) |
Dec 2010 | $9.14 B(+373.5%) | $2.88 B(+27.7%) | $9.14 B(+15.0%) |
Sept 2010 | - | $2.25 B(-24.6%) | $7.95 B(+56.5%) |
June 2010 | - | $2.99 B(+192.1%) | $5.08 B(+105.2%) |
Mar 2010 | - | $1.02 B(-39.3%) | $2.48 B(+28.2%) |
Dec 2009 | $1.93 B(-63.4%) | $1.69 B(-373.8%) | $1.93 B(+121.1%) |
Sept 2009 | - | -$615.40 M(-260.3%) | $873.30 M(-69.5%) |
June 2009 | - | $383.80 M(-19.6%) | $2.86 B(-19.8%) |
Mar 2009 | - | $477.50 M(-23.9%) | $3.56 B(-32.4%) |
Dec 2008 | $5.27 B(-11.9%) | $627.40 M(-54.2%) | $5.27 B(-21.4%) |
Sept 2008 | - | $1.37 B(+25.8%) | $6.71 B(-17.3%) |
June 2008 | - | $1.09 B(-50.2%) | $8.11 B(-16.4%) |
Mar 2008 | - | $2.19 B(+6.0%) | $9.70 B(+62.1%) |
Dec 2007 | $5.99 B | $2.06 B(-25.6%) | $5.99 B(+10.8%) |
Sept 2007 | - | $2.77 B(+3.4%) | $5.41 B(+39.0%) |
June 2007 | - | $2.68 B(-275.3%) | $3.89 B(+23.6%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Mar 2007 | - | -$1.53 B(-203.3%) | $3.15 B(-45.6%) |
Dec 2006 | $5.79 B(-6.8%) | $1.48 B(+17.8%) | $5.79 B(-6.1%) |
Sept 2006 | - | $1.26 B(-35.1%) | $6.16 B(-9.4%) |
June 2006 | - | $1.94 B(+74.7%) | $6.80 B(+7.6%) |
Mar 2006 | - | $1.11 B(-40.3%) | $6.32 B(+1.8%) |
Dec 2005 | $6.21 B(-12.3%) | $1.86 B(-1.9%) | $6.21 B(+0.1%) |
Sept 2005 | - | $1.89 B(+29.9%) | $6.20 B(+1.4%) |
June 2005 | - | $1.46 B(+46.3%) | $6.11 B(-7.1%) |
Mar 2005 | - | $996.20 M(-46.2%) | $6.58 B(-7.0%) |
Dec 2004 | $7.07 B(-11.0%) | $1.85 B(+2.4%) | $7.07 B(-5.8%) |
Sept 2004 | - | $1.81 B(-6.0%) | $7.51 B(-14.8%) |
June 2004 | - | $1.92 B(+29.0%) | $8.82 B(+9.5%) |
Mar 2004 | - | $1.49 B(-34.8%) | $8.05 B(+1.3%) |
Dec 2003 | $7.95 B(+11.0%) | $2.29 B(-26.6%) | $7.95 B(+2.5%) |
Sept 2003 | - | $3.12 B(+169.0%) | $7.75 B(+8.0%) |
June 2003 | - | $1.16 B(-16.5%) | $7.18 B(+2.0%) |
Mar 2003 | - | $1.39 B(-33.6%) | $7.04 B(-1.7%) |
Dec 2002 | $7.16 B(+20.5%) | $2.09 B(-17.8%) | $7.16 B(+4.8%) |
Sept 2002 | - | $2.54 B(+150.0%) | $6.83 B(+4.5%) |
June 2002 | - | $1.02 B(-32.6%) | $6.54 B(+10.6%) |
Mar 2002 | - | $1.51 B(-14.3%) | $5.91 B(-0.5%) |
Dec 2001 | $5.94 B(+19.8%) | $1.76 B(-21.7%) | $5.94 B(+6.8%) |
Sept 2001 | - | $2.25 B(+473.6%) | $5.56 B(+28.4%) |
June 2001 | - | $392.10 M(-74.5%) | $4.33 B(-11.9%) |
Mar 2001 | - | $1.54 B(+11.3%) | $4.92 B(-0.8%) |
Dec 2000 | $4.96 B(+38.9%) | $1.38 B(+36.0%) | $4.96 B(+21.1%) |
Sept 2000 | - | $1.02 B(+3.7%) | $4.10 B(+2.9%) |
June 2000 | - | $980.00 M(-38.0%) | $3.98 B(+8.8%) |
Mar 2000 | - | $1.58 B(+204.1%) | $3.66 B(+2.5%) |
Dec 1999 | $3.57 B(+6.4%) | $519.50 M(-42.3%) | $3.57 B(-1.9%) |
Sept 1999 | - | $900.40 M(+36.7%) | $3.64 B(-1.7%) |
June 1999 | - | $658.70 M(-55.8%) | $3.70 B(+1.7%) |
Mar 1999 | - | $1.49 B(+153.7%) | $3.64 B(+8.4%) |
Dec 1998 | $3.35 B(-31.1%) | $588.00 M(-38.9%) | $3.35 B(-21.3%) |
Sept 1998 | - | $961.70 M(+61.4%) | $4.26 B(-6.1%) |
June 1998 | - | $595.80 M(-50.7%) | $4.54 B(-6.3%) |
Mar 1998 | - | $1.21 B(-19.2%) | $4.85 B(-0.5%) |
Dec 1997 | $4.87 B(+15.1%) | $1.50 B(+20.9%) | $4.87 B(-0.8%) |
Sept 1997 | - | $1.24 B(+37.2%) | $4.91 B(+5.4%) |
June 1997 | - | $902.00 M(-26.8%) | $4.66 B(+2.5%) |
Mar 1997 | - | $1.23 B(-19.9%) | $4.54 B(+7.4%) |
Dec 1996 | $4.23 B(+118.2%) | $1.54 B(+56.2%) | $4.23 B(+20.7%) |
Sept 1996 | - | $984.60 M(+24.6%) | $3.50 B(+9.1%) |
June 1996 | - | $790.40 M(-13.9%) | $3.21 B(+21.5%) |
Mar 1996 | - | $918.00 M(+13.2%) | $2.64 B(+36.3%) |
Dec 1995 | $1.94 B(-38.1%) | $811.20 M(+17.1%) | $1.94 B(+5.3%) |
Sept 1995 | - | $692.60 M(+212.8%) | $1.84 B(-16.5%) |
June 1995 | - | $221.40 M(+3.7%) | $2.21 B(-22.6%) |
Mar 1995 | - | $213.50 M(-70.1%) | $2.85 B(-8.9%) |
Dec 1994 | $3.13 B(+53.8%) | $714.40 M(-32.5%) | $3.13 B(+4.0%) |
Sept 1994 | - | $1.06 B(+22.0%) | $3.01 B(+10.2%) |
June 1994 | - | $867.10 M(+76.5%) | $2.73 B(+33.6%) |
Mar 1994 | - | $491.30 M(-17.3%) | $2.04 B(+0.4%) |
Dec 1993 | $2.04 B(+41.6%) | $593.90 M(-23.8%) | $2.04 B(+5.2%) |
Sept 1993 | - | $779.90 M(+335.2%) | $1.94 B(+18.9%) |
June 1993 | - | $179.20 M(-62.9%) | $1.63 B(+2.5%) |
Mar 1993 | - | $482.80 M(-2.1%) | $1.59 B(+10.4%) |
Dec 1992 | $1.44 B(+3.3%) | $493.10 M(+4.5%) | $1.44 B(+8.0%) |
Sept 1992 | - | $471.80 M(+237.7%) | $1.33 B(+0.1%) |
June 1992 | - | $139.70 M(-58.1%) | $1.33 B(+5.4%) |
Mar 1992 | - | $333.20 M(-13.8%) | $1.26 B(-9.4%) |
Dec 1991 | $1.39 B(+0.6%) | $386.60 M(-17.8%) | $1.39 B(+1.4%) |
Sept 1991 | - | $470.10 M(+557.5%) | $1.37 B(+10.1%) |
June 1991 | - | $71.50 M(-84.6%) | $1.25 B(-13.6%) |
Mar 1991 | - | $464.30 M(+26.2%) | $1.44 B(+4.3%) |
Dec 1990 | $1.38 B(+46.1%) | $368.00 M(+7.1%) | $1.38 B(+36.2%) |
Sept 1990 | - | $343.50 M(+28.1%) | $1.02 B(+51.0%) |
June 1990 | - | $268.20 M(-33.8%) | $673.30 M(+66.2%) |
Mar 1990 | - | $405.10 M | $405.10 M |
Dec 1989 | $947.70 M | - | - |
FAQ
- What is Merck & Co annual free cash flow?
- What is the all time high annual FCF for Merck & Co?
- What is Merck & Co annual FCF year-on-year change?
- What is Merck & Co quarterly free cash flow?
- What is the all time high quarterly FCF for Merck & Co?
- What is Merck & Co quarterly FCF year-on-year change?
- What is Merck & Co TTM free cash flow?
- What is the all time high TTM FCF for Merck & Co?
- What is Merck & Co TTM FCF year-on-year change?
What is Merck & Co annual free cash flow?
The current annual FCF of MRK is $9.14 B
What is the all time high annual FCF for Merck & Co?
Merck & Co all-time high annual free cash flow is $14.71 B
What is Merck & Co annual FCF year-on-year change?
Over the past year, MRK annual free cash flow has changed by -$5.56 B (-37.83%)
What is Merck & Co quarterly free cash flow?
The current quarterly FCF of MRK is $8.51 B
What is the all time high quarterly FCF for Merck & Co?
Merck & Co all-time high quarterly free cash flow is $8.51 B
What is Merck & Co quarterly FCF year-on-year change?
Over the past year, MRK quarterly free cash flow has changed by +$1.69 B (+24.84%)
What is Merck & Co TTM free cash flow?
The current TTM FCF of MRK is $14.84 B
What is the all time high TTM FCF for Merck & Co?
Merck & Co all-time high TTM free cash flow is $15.25 B
What is Merck & Co TTM FCF year-on-year change?
Over the past year, MRK TTM free cash flow has changed by +$1.67 B (+12.71%)